Unknown

Dataset Information

Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.


ABSTRACT:

Background

Statins have immunomodulatory properties that may provide beneficial effects in the treatment of COPD. We investigated whether a statin improves the IL-17/IL-10 imbalance in patients with COPD, as has previously been demonstrated in patients with asthma.

Methods

Thirty patients with stable COPD were recruited to a double-blind, randomized, controlled, crossover trial comparing the effect of simvastatin, 20 mg po daily, with that of a matched placebo on sputum inflammatory markers and airway inflammation. Each treatment was administered for 4 weeks separated by a 4-week washout period. The primary outcome was the presence of T-helper 17 cytokines and indoleamine 2,3-dioxygenase (IDO) in induced sputum. Secondary outcomes included sputum inflammatory cells, FEV1, an

SUBMITTER: Maneechotesuwan K 

PROVIDER: S-EPMC4631035 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature